Safe Orthopaedics SA (EPA:ALSAF)

Safe Orthopaedics Statistics

Total Valuation

EPA:ALSAF has a market cap or net worth of EUR 78,452. The enterprise value is 11.55 million.

Market Cap	78,452
Enterprise Value	11.55M

Important Dates

The next estimated earnings date is Wednesday, April 29, 2026.

Earnings Date	Apr 29, 2026
Ex-Dividend Date	n/a

Share Statistics

EPA:ALSAF has 91,223 shares outstanding.

Current Share Class	91,223
Shares Outstanding	91,223
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.02
PB Ratio	-0.01
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-0.01
EV / Sales	2.29
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-3.44

Financial Position

The company has a current ratio of 0.39

Current Ratio	0.39
Quick Ratio	0.20
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	-3.51
Interest Coverage	-0.00

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-3.44%
Return on Invested Capital (ROIC)	-4.24%
Return on Capital Employed (ROCE)	35.34%
Weighted Average Cost of Capital (WACC)	14,123.76%
Revenue Per Employee	65,468
Profits Per Employee	-25.06M
Employee Count	77
Asset Turnover	0.11
Inventory Turnover	0.65

Taxes

In the past 12 months, EPA:ALSAF has paid 65.21 million in taxes.

Income Tax	65.21M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -92.79% in the last 52 weeks. The beta is -0.96, so EPA:ALSAF's price volatility has been lower than the market average.

Beta (5Y)	-0.96
52-Week Price Change	-92.79%
50-Day Moving Average	1.35
200-Day Moving Average	2.20
Relative Strength Index (RSI)	36.10
Average Volume (20 Days)	9,739

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, EPA:ALSAF had revenue of EUR 5.04 million and -1.93 billion in losses. Loss per share was -0.93.

Revenue	5.04M
Gross Profit	2.57M
Operating Income	-2.45M
Pretax Income	-1.86B
Net Income	-1.93B
EBITDA	-2.00M
EBIT	-2.45M
Loss Per Share	-0.93

Balance Sheet

The company has 317,000 in cash and 11.79 million in debt, with a net cash position of -11.47 million or -125.75 per share.

Cash & Cash Equivalents	317,000
Total Debt	11.79M
Net Cash	-11.47M
Net Cash Per Share	-125.75
Equity (Book Value)	-8.42M
Book Value Per Share	n/a
Working Capital	-10.96M

Cash Flow

In the last 12 months, operating cash flow was -3.27 million and capital expenditures -93,000, giving a free cash flow of -3.36 million.

Operating Cash Flow	-3.27M
Capital Expenditures	-93,000
Free Cash Flow	-3.36M
FCF Per Share	-36.83

Margins

Gross Margin	50.88%
Operating Margin	-48.54%
Pretax Margin	-36,979.03%
Profit Margin	n/a
EBITDA Margin	-39.58%
EBIT Margin	-48.54%
FCF Margin	n/a

Dividends & Yields

EPA:ALSAF does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-2,459,240.04%
FCF Yield	-4,282.87%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on July 7, 2025. It was a reverse split with a ratio of 0.001.

Last Split Date	Jul 7, 2025
Split Type	Reverse
Split Ratio	0.001

Scores

EPA:ALSAF has an Altman Z-Score of -246.26 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-246.26
Piotroski F-Score	1